AVAIRA SPHERIC AND TORIC (ENFILCON A) SOFT CONTACT LENS

K133627 · CooperVision, Inc. · LPL · Dec 23, 2013 · Ophthalmic

Device Facts

Record IDK133627
Device NameAVAIRA SPHERIC AND TORIC (ENFILCON A) SOFT CONTACT LENS
ApplicantCooperVision, Inc.
Product CodeLPL · Ophthalmic
Decision DateDec 23, 2013
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 886.5925
Device ClassClass 2

Intended Use

AVAIRA (enfilcon A) SPHERE Soft (Hydrophilic) Contact Lenses are indicated for the correction of ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes. The lenses may be worn by persons who exhibit astigmatism of 2.00 diopters or less that does not interfere with visual acuity. AVAIRA (enfilcon A) TORIC Soft (Hydrophilic) Contact Lenses are indicated for the correction of visual ametropia (myopia or hyperopia with astigmatism) in aphakic and non-aphakic persons with non-diseased eyes in powers from -20.00 to +20.00 diopters and astigmatic corrections from -0.25 to -10.00 diopters. DAILY DISPOSABLE: The AVAIRA (enfilcon A) Soft (hydrophilic) Contact Lenses are indicated for single-use disposable wear. FREQUENT REPLACEMENT: The AVAIRA (enfilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear. When prescribed for planned replacement the lens may be disinfected using a chemical or hydrogen peroxide disinfecting system.

Device Story

Silicone hydrogel contact lens; hemispherical shell; enfilcon A material; incorporates phthalocyanine blue handling tint and UV blocker. Device fits over corneal surface to provide refractive correction for ametropia. Manufacturing process modification adds monomer sonication step. No changes to physical properties, dimensions, or formulation. Used by patients for daily wear; prescribed by eye care professionals. Output is visual correction; benefits patient by improving visual acuity.

Clinical Evidence

No clinical data. Bench testing only. Physicochemical studies (refractive index, total extractables, monomer residuals, ionoflux, contact angle, UV transmission, modulus, elongation, tensile strength, power conformance) demonstrated that the modified manufacturing process resulted in no significant change to lens properties.

Technological Characteristics

Silicone hydrogel (enfilcon A); non-surface treated; 46% water content; oxygen permeability 100 (cm²/sec)(ml O₂)/ml*mmHg; refractive index 1.40; base curve 8.2-9.2 mm; diameter 13.5-15.0 mm; UV blocker included; monomer sonication step added to manufacturing.

Indications for Use

Indicated for correction of ametropia (myopia/hyperopia) in aphakic and non-aphakic persons with non-diseased eyes. Sphere lenses for astigmatism ≤2.00D. Toric lenses for astigmatism -0.25 to -10.00D. Powers -20.00 to +20.00D.

Regulatory Classification

Identification

A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ CooperVision, Inc. #### K133627 ## 510k Summary AVAIRA (enfilcon A) Sphere and Toric Contact Lenses 12/20/2013 DEC 2 3 2013 | Applicant: | CooperVision, Inc.<br>6150 Stoneridge Mall Road, Suite 370<br>Pleasanton, CA 94588 USA | |------------------------|------------------------------------------------------------------------------------------------------| | Applicant Contact: | Annette Nelson<br>Senior Regulatory Affairs Specialist<br>925-621-2453 (phone)<br>925-621-2488 (fax) | | Email: | anelson@coopervision.com | | Date Prepared: | November 15, 2013 | | Device Trade Name: | AVAIRA Sphere and Toric Soft Contact Lenses | | Common/Usual Name: | Enfilcon A Soft (Hydrophilic) Contact Lens | | Classification Name: | Soft (Hydrophilic) Contact Lens, Daily Wear, Disposable | | Device Classification: | Class II (21 CFR 886.5925); Product Codes MVN and LPL | | Predicate Devices: | AVAIRA Sphere and Toric Soft Contact Lenses<br>(K071736/K113759) | ## Device Description: The Avaira (enfilcon A) soft contact lens is a daily wear silicone hydrogel contact lens that is not surface treated and is characterized by a high oxygen permeability (Dk). The lens material, enfilcon A, is composed of silicone macromers cross linked with other monomers, incorporating phthalocyanine blue as an integrated handling tint. A UV blocker is added to reduce the amount of ultraviolet light transmitted into the eye. The Avaira (enfilcon A) Soft (hydrophilic) contact lenses are a hemispherical shell. This 510(k) submission covers a process modification to add a step to the preparation of the monomer mixture. The physical properties and dimensions of the finished lenses are unchanged from predicate 510(k)s. ### Intended Use: #### SPHERICAL: Avaira (enfilcon A) SPHERE Soft Contact lenses are indicated for the correction of ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes. The Cooper Vision, Inc. AVAIRA (enfilcon A) Contact Lens 510(k) {1}------------------------------------------------ lenses may be worn by persons who exhibit astigmatism of 2.00 diopters or less that does not interfere with visual acuity. #### TORIC: Avaira (enfilcon A) TORIC Soft Contact lenses are indicated for the correction of ametropia (myopia or hyperopia with astigmatism) in aphakic and non-aphakic persons with non-diseased eyes in powers from -20.00 to +20.00 diopters and astigmatic corrections from -0.25 to -10.00 diopters. #### Physiochemical Studies In-vitro studies measuring the physical, optical and chemical properties of lenses subjected to the modified manufacturing process were performed. The results show there is no significant change to the physicochemical properties of the lenses. | Tested Characteristics | Results | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------| | Refractive Index, Total Extractables, Monomer<br>Residuals, Ionoflux, Contact Angle, UV Transmission,<br>Modulus, Elongation, Tensile Strength, and Power<br>Conformance | Pass | #### Clinical Studies In-vivo clinical studies were not required for this change, as the dimensions, formulation, lens manufacturing process, and product specifications remain the same. #### Conclusion #### Validity of Scientific Data Physiochemical studies were conducted by CooperVision following scientific protocols. #### Substantial Equivalence The information presented in this submission establishes the substantial equivalence of the modified AVAIRA (enfilcon A) SPHERE and TORIC daily wear contact lenses to the predicate devices. The following table summarizes the substantial equivalence comparison information. {2}------------------------------------------------ : and the comments of the comments of . : . . . . | Substantial Equivalence Comparison | | | |--------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------| | Characteristic | AVAIRA SPHERE and TORIC<br>(K071736/K113759) | AVAIRA SPHERE and TORIC<br>(This Submission) | | Indications for Use<br>AVAIRA SPHERE | Correction of ametropia in aphakic<br>and non-aphakic persons with non-<br>diseased eyes and astigmatism<br>≤2.00 diopters | Same | | Indications for Use<br>AVAIRA TORIC | Correction of ametropia (myopia<br>or hyperopia with astigmatism) in<br>aphakic and non-aphakic persons<br>with non-diseased eyes in powers<br>from -20.00 to +20.00 diopters and<br>astigmatic correction from -0.25 to<br>-10.00 diopters | Same | | Single Use | Single-use, disposable | Same | | Replacement | Daily Wear, disinfect using<br>chemical or hydrogen peroxide<br>disinfectant when prescribed for<br>planned replacement | Same | | Material USAN Name | enfilcon A | Same | | Principle of Operation | Designed to fit over corneal<br>surface of eye to provide<br>corrective refraction for<br>functional conditions of the eye | Same | | Refractive Index | 1.40 | Same | | Oxygen Permeability x 10-11 | 100 (cm²/sec)(ml O₂)/ml*mmHg) | Same | | Base Curve | 8.2 to 9.2 mm | Same | | Diameter | 13.5 to 15.0 mm | Same | | Power Range | -20.00 to +20.00 D | Same | | Cylinder Power | -0.25 to -10.00 D | Same | | Water Content (avg, %wt) | 46% | 46% | | Monomer sonication step | No | Yes | . {3}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/3/Picture/1 description: The image shows a partial view of a seal or emblem. The visible text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circular fashion around the edge of the emblem. The central part of the emblem features a stylized design, possibly representing a caduceus or a similar symbol associated with health and medicine. The image is in black and white, with the text and design elements appearing in solid black against a white background. December 23, 2013 Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 CooperVision, Inc. % Ms. Annette Nelson Senior Regulatory Affairs Specialist 6150 Stoneridge Mall Road, Suite 370 Pleasanton, CA 94588 Re: K133627 Trade/Device Name: AVAIRA Sphere and Toric Soft Contact Lenses Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) Contact Lens Regulatory Class: Class II Product Code: LPL Secondary Product Code: MVN Dated: November 15, 2013 Received: November 26, 2013 Dear Ms. Nelson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. {4}------------------------------------------------ Page 2 - Ms. Annette Nelson You must comply with all the Act's requirements, including, but not limited to: Registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, # Deborah L. Falls -S for Malvina B. Eydelman. M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health {5}------------------------------------------------ CooperVision, Inc. # Indications for Use 510(k) Number: K133627 Device Name: AVAIRA (enfilcon A) Sphere and Toric Soft Contact Lenses Indications For Use: A VAIRA (enfilcon A) SPHERE Soft (Hydrophilic) Contact Lenses are indicated for the correction of ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes. The lenses may be worn by persons who exhibit astigmatism of 2.00 diopters or less that does not interfere with visual acuity. AVAIRA (enfilcon A) TORIC Soft (Hydrophilic) Contact Lenses are indicated for the correction of visual ametropia (myopia or hyperopia with astigmatism) in aphakic and non-aphakic persons with non-diseased eyes in powers from -20.00 to +20.00 diopters and astigmatic corrections from -0.25 to -10.00 diopters. DAILY DISPOSABLE: The AVAIRA (enfilcon A) Soft (hydrophilic) Contact Lenses are indicated for single-use disposable wear. FREQUENT REPLACEMENT: The AVAIRA (enfilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear. When prescribed for planned replacement the lens may be disinfected using a chemical or hydrogen peroxide disinfecting system. Prescription Use X ______________________________________________________________________________________________________________________________________________________________________________ (part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Jeffrey M. Brocious -S 2013.12.20 13:46:29 -05'00' (Division Sign-Off) Division of Ophthalmic and Ear, Nose, and Throat Devices 510(k) Number: K133627 Page 1 of K133627 Cooper Vision Inc., AVAIRA (enfilcon A) Contact Lens 510(k)
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...